TRAUMON 100 mg /Ml Aerosol

Contents of the leaflet

1. Leaflet attached to the packaging: patient information
2. TRAUMON, 100 mg/ml, spray for the skin, solution
   1. Please read carefully the contents of the leaflet before using the medicine, as it contains
   2. Table of contents of the leaflet
3. What is Traumon and what is it used for
   1. Indications:
4. Important information before using Traumon
   1. When not to use Traumon
   2. Warnings and precautions
   3. Traumon, spray for the skin, solution and other medicines
   4. Pregnancy and breastfeeding
   5. Driving and using machines
   6. Traumon, spray for the skin, solution contains propylene glycol
5. How to use Traumon
   1. Using a higher dose of Traumon than recommended
   2. Missing a dose of Traumon
6. Possible side effects
   1. Reporting side effects
7. How to store Traumon
8. Contents of the packaging and other information
   1. What Traumon contains
   2. What Traumon looks like and contents of the pack
   3. Marketing authorization holder:
   4. Manufacturer:
   5. For further information, please contact:
   6. Date of last revision of the leaflet:

Leaflet attached to the packaging: patient information

TRAUMON, 100 mg/ml, spray for the skin, solution

Etofenamate

Please read carefully the contents of the leaflet before using the medicine, as it contains

important information for the patient.
This medicine should always be used exactly as described in the patient leaflet or according to
the doctor's or pharmacist's instructions.

• This leaflet should be kept in case it needs to be read again.
• If advice or additional information is needed, the pharmacist should be consulted.
• If the patient experiences any side effects, including any possible side effects not listed in the leaflet, they should inform their doctor or pharmacist. See section 4.
• If there is no improvement or the patient feels worse, they should contact their doctor.

Table of contents of the leaflet

• 1. What is Traumon and what is it used for
• 2. Important information before using Traumon
• 3. How to use Traumon
• 4. Possible side effects
• 5. How to store Traumon
• 6. Contents of the packaging and other information

1. What is Traumon and what is it used for

Etofenamate - the active substance of Traumon, has anti-inflammatory and analgesic effects. Etofenamate
belongs to the group of nonsteroidal anti-inflammatory drugs (NSAIDs). When applied topically, it is absorbed through the skin and accumulates in inflamed tissues.
Topical application reduces the risk of side effects typical of NSAIDs taken orally.
Traumon does not leave a greasy layer on the skin.

Indications:

• Blunt injuries, such as: bruises, sprains, muscle strains, tendon and joint injuries
• Degenerative joint disease of the spine, knees, shoulders
• Extra-articular rheumatism:
• low back pain
• diseases of the soft tissues around the joints, such as bursitis, tendinitis, synovitis (so-called frozen shoulder)
• prepatellar bursitis.

2. Important information before using Traumon

When not to use Traumon

• if the patient is hypersensitive (allergic) to etofenamate, flufenamic acid, other nonsteroidal anti-inflammatory drugs or any of the other ingredients of this medicine (listed in section 6),
• during the third trimester of pregnancy,
• in children and adolescents.

Warnings and precautions

• Traumon should not be used in case of skin damage or inflammatory rashes on the skin, as well as on mucous membranes or eyes, therefore after using the medicine, hands should be washed or contact with these parts of the body should be avoided.
• During treatment and for two weeks after treatment, exposure of the treated areas to the sun and/or solarium should be avoided.
• Patients with asthma, chronic obstructive pulmonary disease, hay fever or chronic nasal polyps or chronic respiratory infections, especially in combination with symptoms similar to hay fever, may use Traumon only under certain precautions and under strict medical supervision.
• Systemic absorption may increase if the medicine is used for a longer period and/or on large areas of the body. Such use should therefore be avoided.
• Children should not come into contact with skin covered with this medicine.

Traumon, spray for the skin, solution and other medicines

The doctor or pharmacist should be informed about all medicines currently or recently used by the patient,
as well as about medicines that the patient plans to use.
No interactions have been found when Traumon is used as recommended.

Pregnancy and breastfeeding

If the patient is pregnant or breastfeeding, thinks she may be pregnant or plans to have a child, she should consult her doctor before using this medicine.
Traumon should be used in the first and second trimester of pregnancy only after the doctor has assessed the benefit-risk ratio. The recommended daily dose should not be exceeded.
Traumon should not be used in women in the third trimester of pregnancy.
Since etofenamate passes into breast milk to a small extent, breastfeeding mothers should avoid prolonged use of Traumon and should not exceed the recommended daily dose.
The medicine should not be used on the breasts.

Driving and using machines

No studies have been conducted on the effects of the medicine on the ability to drive vehicles and operate machinery.

Traumon, spray for the skin, solution contains propylene glycol

This medicine contains 7.2 mg of propylene glycol (E 1520) per dose (spray) which corresponds to 40 mg of propylene glycol per 1 ml of solution.
Propylene glycol may cause skin irritation.
Due to the presence of propylene glycol, the medicine should not be used on open wounds or large areas of damaged or broken skin (e.g. burned skin) without consulting a doctor or pharmacist.

3. How to use Traumon

This medicine should always be used exactly as described in the patient leaflet or according to the doctor's or pharmacist's instructions. In case of doubts, the doctor or pharmacist should be consulted.
Unless the doctor recommends otherwise, the area of skin affected by pain should be sprayed 3 to 5 times a day, covering an area slightly larger than the painful area. Usually, a single application of up to 7 doses of Traumon is sufficient, but the dose can be increased if necessary. After every 1 to 2 doses, the medicine should be gently rubbed into the skin and allowed to dry.
Treatment of rheumatic conditions usually lasts 3 to 4 weeks, and blunt injuries (e.g. sports injuries) - up to 2 weeks.
If the patient feels that the effect of the medicine is too strong or too weak, they should consult their doctor.

Using a higher dose of Traumon than recommended

No cases of overdose of Traumon have been reported when used as recommended.
In case of applying the contents of the entire bottle of Traumon and covering the entire body with it in a short time, headaches and dizziness as well as abdominal discomfort may occur. In such a case, the medicine should be washed off the skin with water.
If the patient or child accidentally ingests the medicine, they should see a doctor.

Missing a dose of Traumon

A double dose should not be used to make up for a missed dose.
In case of any further doubts about using the medicine, the doctor or pharmacist should be consulted.

4. Possible side effects

Like all medicines, Traumon can cause side effects, although not everybody gets them.
Disorders of the skin and subcutaneous tissue
Uncommon side effects (may occur with a frequency of less than 1 in 100 but more than 1 in 1,000 people):

• redness, skin burning.

Rare side effects (may occur with a frequency of less than 1 in 10,000 people):

• skin inflammation, such as severe itching, rash, swelling, blistering rash.

Frequency not known (frequency cannot be estimated from the available data):

• phototoxic reaction.

The above side effects usually disappear after the medicine is discontinued.
Immune system disorders:
Frequency not known (frequency cannot be estimated from the available data):

• hypersensitivity (non-specific allergic reaction and anaphylaxis, increased respiratory tract reactivity leading to asthma, asthma exacerbation, bronchospasm or shortness of breath, various skin disorders, including rash, itching, urticaria, angioedema, and rare exfoliative and blistering skin changes (including toxic epidermal necrolysis and erythema multiforme).

If such symptoms occur, which is possible even after the first administration of the medicine, the patient should immediately seek medical attention.

Reporting side effects

If any side effects occur, including any side effects not listed in the leaflet, the doctor or pharmacist should be informed. Side effects can be reported directly to the Department of Monitoring of Adverse Reactions to Medicinal Products of the Office for Registration of Medicinal Products, Medical Devices and Biocidal Products,
Aleje Jerozolimskie 181C, 02-222 Warsaw, tel.: +48 22 49 21 301, fax: +48 22 49 21 309, website: https://smz.ezdrowie.gov.pl
Side effects can also be reported to the marketing authorization holder.
Reporting side effects will help to gather more information on the safety of the medicine.

5. How to store Traumon

Keep out of the reach and sight of children.
Store at a temperature below 25°C.
Do not use this medicine after the expiry date stated on the carton.
The expiry date refers to the last day of the month.
Medicines should not be disposed of via wastewater or household waste. The pharmacist should be asked how to dispose of medicines that are no longer needed. This will help protect the environment.

6. Contents of the packaging and other information

What Traumon contains

• The active substance of Traumon is etofenamate (Etofenamatum).
• The excipients of Traumon are: diisopropyl adipate, macrogol oleate (Emulgin M8 Deo), macrogol 400, isopropyl alcohol, propylene glycol, purified water. The medicine contains 40 mg of propylene glycol (E 1520) per 1 ml of solution. See also "Traumon, spray for the skin, solution contains propylene glycol" in section 2.

What Traumon looks like and contents of the pack

The pack contains a brown glass bottle with a dispenser in a cardboard box.
Pack size: 50 ml.

Marketing authorization holder:

Cooper Consumer Health B.V.
Verrijn Stuartweg 60
1112AX Diemen
Netherlands

Manufacturer:

Madaus GmbH
51101 Köln
Germany

For further information, please contact:

Viatris Healthcare Sp. z o.o.
tel.: 22 546 64 00

Date of last revision of the leaflet: